Amelio Biotech, established in 2016, is committed to developing products that are both life-friendly and efficient. The company name "Amelio" is derived from the English word "Ameliorate," meaning to improve.
The core technology of the company is amino acid supramolecular technology, aimed at creating a new generation of products combining amino acids and mineral elements. This technology is further applied and expanded within the life sciences industry.
We create a new type of click chemistry. AACS is a unique and powerful atom-economy system which conjugates amino acids and target molecules as easily as building toy blocks.
AACS can be applied in several fields, including making small molecules that can kill cancer cells without harming healthy cells, delivering drugs through amino acid carriers, and making various health supplements.
READ MORERapid and effective blood clotting with excellent biocompatibility.
Enhancing human health by addressing mineral deficiencies.
Utilizing AACS technology, we have developed a new molecule, AMBG1, which has shown excellent inhibitory effects on various cancer cells.
Improving animal nutrition and disease resistance.
Every AACS molecule is fully absorbed by nature.
Founded with the vision of creating a better future through innovative agricultural solutions, Amelio Biomedical has rapidly advanced in developing our unique AACS technology. We have partnered with leading organizations and secur
The Amelio Biomedical R&D team continuously drives innovation and application of AACS technology. We collaborate with international companies and institutions to promote global application. For more information or collaboration opportunities, please contact us.
CONTACT US